Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Inflammatory Bowel Disease
•
General Rheumatology
•
Gastroenterology
•
TNF inhibitor
•
Immunosuppression
•
Anaphylaxis
In patients with history of anaphylaxis to a TNF inhibitor, are you comfortable trying an alternative TNF inhibitor?
Related Questions
What are your vaccine recommendations while patients are on biologics?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
Do you continue TNF inhibitors in patients with a new diagnosis of CLL?
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
In light of recent measles outbreaks, have you adjusted your vaccination counseling or preventive strategies for adult immunocompromised patients?
Have you utilized JAK inhibitors in patients on dialysis?
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
Should the age at which patients transition from pediatric to adult care differ depending on the disease diagnosis?
How often do you see bony erosions in patients with Lyme arthritis?
How do you approach a patient with high titer ANA and a new diagnosis of ITP, but no other signs or symptoms suggestive of active rheumatologic disease?
